Cell Biology • Membranes and Transport

Endocytosis & Exocytosis — Explain endocytosis (phagocytosis, pinocytosis, receptor-mediated) and exocytosis

How cells internalize macromolecules and secrete cargo through vesicle-mediated membrane trafficking.

A microscope examining cellular structures alongside a DNA strand.
Inside this lesson 10 sections 5 questions 5 figures

SECTION 1

Historical Context & Motivation

The discovery that living cells actively engulf material from their surroundings—and that they also release molecules outward through membrane-bound vesicles—transformed cell biology from a largely descriptive field into one centered on dynamic membrane trafficking. For most of the nineteenth century, the cell membrane was viewed as a passive barrier, a simple boundary separating the interior from the exterior. The realization that the membrane is a fluid, selectively permeable bilayer capable of budding, fusing, and recycling vesicles opened entirely new avenues for understanding nutrient uptake, immune defense, and intercellular communication.

Early microscopists observed white blood cells engulfing bacteria, yet the molecular underpinnings of such processes would remain elusive for decades. The concept that cells could internalize extracellular material through membrane invagination was formalized as endocytosis, while the complementary process of releasing intracellular cargo via vesicle fusion with the plasma membrane became known as exocytosis. Together, these pathways constitute a core axis of vesicular transport that maintains membrane homeostasis, mediates signal transduction, and governs the secretory pathway.

1882 • Metchnikoff & Phagocytosis

Élie Metchnikoff observed starfish larvae engulfing foreign particles and coined the term phagocytosis (from Greek phagein, 'to eat'), establishing the foundation of cellular innate immunity.

1931 • Lewis Describes Pinocytosis

Warren Lewis used time-lapse microscopy of cultured macrophages to describe pinocytosis ('cell drinking'), the uptake of small volumes of extracellular fluid through tiny vesicles.

1964 • De Duve & Lysosomes

Christian de Duve received the Nobel Prize for the discovery of lysosomes, the organelles that degrade material delivered by endocytic vesicles, completing the concept of an intracellular digestive compartment.

1975 • Goldstein & Brown — Receptor-Mediated Endocytosis

Joseph Goldstein and Michael Brown elucidated the LDL receptor pathway, demonstrating that cells use receptor-mediated endocytosis via clathrin-coated pits to internalize specific ligands with high efficiency.

2013 • Nobel Prize for Vesicular Trafficking

Rothman, Schekman, and Südhof shared the Nobel Prize in Physiology or Medicine for discoveries of machinery regulating vesicle traffic—including SNARE proteins essential for exocytosis.

These milestones frame a fundamental question in membrane biology: how does a cell selectively move macromolecules, particles, and even entire microorganisms across a lipid bilayer that is inherently impermeable to such cargo? Answering this question requires understanding the molecular machinery of vesicle formation, the energy requirements of membrane curvature, and the regulatory logic of coat proteins, GTPases, and SNARE complexes that orchestrate every budding and fusion event.

SECTION 2

Core Principles & Definitions

Endocytosis and exocytosis are both classified as bulk (vesicular) transport mechanisms because they move material in membrane-bound packages rather than through individual channels or carriers. They are distinguished from passive diffusion, facilitated diffusion, and primary or secondary active transport by their reliance on vesicle budding and fusion events. Both processes are energy-dependent, requiring GTP hydrolysis for coat protein assembly and ATP-dependent cytoskeletal reorganization, and both reshape the plasma membrane itself as part of the transport cycle.

1

Endocytosis

The process by which the plasma membrane invaginates to capture extracellular material and pinches off to form an intracellular vesicle. Subtypes include phagocytosis, pinocytosis, and receptor-mediated endocytosis.
2

Exocytosis

The inverse process: intracellular vesicles fuse with the plasma membrane, releasing their contents into the extracellular space. Exocytosis mediates secretion of hormones, neurotransmitters, and extracellular matrix components and also inserts new lipids and proteins into the membrane.
3

Membrane Homeostasis

Endocytosis removes membrane surface area, while exocytosis adds it. The two processes are tightly balanced so that total plasma membrane area remains roughly constant, maintaining cell shape and signaling capacity.
4

Coat Proteins & SNAREs

Clathrin, caveolin, and COP-coated vesicles mediate endocytic budding; SNARE proteins (v-SNAREs on vesicles, t-SNAREs on target membranes) catalyze the membrane fusion step in exocytosis.
5

Energy Dependence

Both pathways consume ATP and GTP. Dynamin, a GTPase, pinches off endocytic vesicles. NSF, an ATPase, disassembles SNARE complexes for recycling after each fusion event.
✦

KEY TAKEAWAY

Think of the plasma membrane as a loading dock at a warehouse. Endocytosis is the act of accepting incoming deliveries—packages are wrapped in membrane material (vesicles) and brought inside for processing. Exocytosis is the reverse: products manufactured inside the warehouse are packaged, transported to the dock, and released to the outside world. Just as a warehouse must manage dock space carefully—clearing incoming pallets to make room for outgoing shipments—the cell precisely balances endocytic membrane retrieval with exocytic membrane addition to keep its surface area constant.

SECTION 3

Visual Explanation — The Endocytic Pathway

Three Types of EndocytosisPHAGOCYTOSIS"Cell eating"BacteriumPseudopods extendPhagosome→ Lysosome fusionPINOCYTOSIS"Cell drinking"Membrane invaginatesaround dissolved solutesSmall vesicleNon-specific uptakeRECEPTOR-MEDIATEDClathrin-coated pitLigandsClathrinReceptors bind ligands;clathrin coat drives buddingCoated vesicleHighly selective uptake
The three major forms of endocytosis are compared side by side. Phagocytosis (left) uses pseudopod extension to engulf large particles into a phagosome. Pinocytosis (center) non-specifically internalizes dissolved solutes in small vesicles. Receptor-mediated endocytosis (right) uses clathrin-coated pits and specific receptor–ligand interactions for highly selective uptake.

All three endocytic pathways share a fundamental sequence: the plasma membrane deforms inward, cargo is captured within the resulting invagination, and the membrane neck is severed—often by the GTPase dynamin—to release a free vesicle into the cytoplasm. Phagocytosis, however, is distinguished by its requirement for actin polymerization to extend pseudopods around large particles (≥ 0.5 µm), whereas pinocytosis and receptor-mediated endocytosis typically rely on clathrin or caveolin coats to curve the membrane around much smaller volumes. Receptor-mediated endocytosis adds a layer of molecular specificity by concentrating ligands through high-affinity receptor binding before the coated pit invaginates, enabling cells to efficiently capture even low-abundance molecules from the extracellular fluid.

Following internalization, the vesicle typically progresses through an early endosome, where sorting decisions occur. Cargo destined for degradation is transferred to late endosomes and ultimately to lysosomes, whereas receptors may be recycled back to the plasma membrane through recycling endosomes. This sorting network ensures that cells reuse expensive receptor proteins while degrading only the internalized ligand.

SECTION 4

Molecular Mechanisms in Detail

Clathrin-Mediated Endocytosis (CME)

The most thoroughly characterized endocytic pathway is clathrin-mediated endocytosis (CME), which underpins receptor-mediated uptake. The process begins when adaptor protein 2 (AP2) recognizes sorting motifs—such as YXXΦ or dileucine sequences—in the cytoplasmic tails of transmembrane receptors. AP2 simultaneously binds the phosphoinositide PI(4,5)P₂ in the inner leaflet of the plasma membrane, anchoring the adaptor complex at the correct location. Once AP2 is positioned, clathrin triskelia are recruited from a cytosolic pool. Each triskelion consists of three heavy chains and three light chains arranged in a three-legged pinwheel. Triskelia self-assemble into a lattice of hexagons and pentagons that progressively curves the membrane into a coated pit roughly 100–150 nm in diameter.

The final scission step is catalyzed by dynamin, a large GTPase that oligomerizes around the neck of the budding vesicle and, upon GTP hydrolysis, constricts it until the membrane severs. The released coated vesicle is rapidly uncoated by the ATPase Hsc70 and its co-chaperone auxilin, liberating clathrin triskelia for reuse. The naked vesicle then fuses with the early endosome, a mildly acidic compartment (pH ≈ 6.0–6.5) where ligand–receptor complexes begin to dissociate.

Phagocytosis — An Actin-Dependent Pathway

Unlike CME, phagocytosis is driven by extensive actin cytoskeleton remodeling. In professional phagocytes—macrophages, neutrophils, and dendritic cells—surface receptors such as Fc receptors (which recognize antibody-coated targets) or complement receptors trigger signaling cascades involving Rho-family GTPases (Rac1, Cdc42). These GTPases activate the Arp2/3 complex and formins, nucleating branched actin networks that push the plasma membrane outward as pseudopods. The pseudopods eventually fuse at their tips, sealing the target in a large phagosome (typically 1–10 µm in diameter). Phagosome maturation involves sequential fusion with early endosomes, late endosomes, and finally lysosomes, culminating in the formation of a phagolysosome with a luminal pH near 4.5, loaded with hydrolytic enzymes that degrade the engulfed material.

Exocytosis — SNARE-Mediated Membrane Fusion

In exocytosis, secretory vesicles originating from the trans-Golgi network are transported along cytoskeletal tracks—typically microtubules via kinesin motors—to the cell periphery. The vesicle carries a v-SNARE (vesicle SNARE, e.g., synaptobrevin/VAMP2 in neurons) on its membrane, which binds cognate t-SNAREs (target SNAREs, e.g., syntaxin-1 and SNAP-25) on the plasma membrane. The v-SNARE and t-SNAREs assemble into a four-helix trans-SNARE complex that zippers from the N-terminal ends toward the C-terminal membrane anchors, drawing the vesicle and target membranes into close apposition (< 1.5 nm). This mechanical force overcomes the repulsive hydration barrier between the two bilayers, catalyzing lipid mixing and fusion-pore formation. After fusion, the SNARE complex is disassembled by NSF (N-ethylmaleimide-sensitive factor) and its adaptor α-SNAP using ATP hydrolysis, recycling the SNAREs for subsequent rounds of fusion.

ℹ

Constitutive vs. Regulated Exocytosis

Cells exhibit two modes of exocytosis. Constitutive exocytosis occurs continuously, delivering membrane proteins and secreted factors without an external trigger. Regulated exocytosis requires a specific stimulus—often a rise in cytosolic Ca²⁺ concentration—to trigger vesicle fusion. Synaptic transmission, insulin release from pancreatic β-cells, and histamine release from mast cells are classic examples of regulated exocytosis where Ca²⁺-sensing proteins such as synaptotagmin act as molecular switches.

SECTION 5

Classification & Comparison of Endocytic Subtypes

FeaturePhagocytosisPinocytosisReceptor-Mediated
Particle sizeLarge (≥ 0.5 µm); bacteria, dead cellsFluid droplets (< 0.1 µm vesicles)Specific ligands; vesicles ~100–150 nm
SelectivitySemi-selective via opsonin receptorsNon-selective; constitutiveHighly selective; ligand–receptor binding
Primary coat / driverActin polymerization; pseudopodsClathrin or caveolin; sometimes clathrin-independentClathrin triskelia; AP2 adaptors
Key cell typesMacrophages, neutrophils, dendritic cellsNearly all eukaryotic cellsHepatocytes (LDL), lymphocytes (transferrin)
Vesicle destinationPhagolysosome (degradation)Early endosome → lysosomeEarly endosome → receptor recycled; ligand degraded
Clinical relevanceImmune defense; defects → chronic granulomatous diseaseKidney proximal tubule reabsorptionLDL receptor mutations → familial hypercholesterolemia

Comparison of the three main endocytic subtypes

Endocytosis vs. Exocytosis — Membrane BalancePLASMA MEMBRANEEXTRACELLULAR SPACECYTOPLASMENDOCYTOSISCargoVesicleEndosomeEXOCYTOSISGolgi vesicleVesicleFusionReleasedMembrane BalanceEndocytosis removes membrane;Exocytosis adds membrane.Net flux ≈ 0 at steady state.
Endocytosis (left, pink) and exocytosis (right, green) operate as complementary processes across the plasma membrane. Endocytic vesicle formation removes membrane surface area, while exocytic vesicle fusion restores it, maintaining overall membrane homeostasis at steady state.

The diagram above emphasizes a critical concept: endocytosis and exocytosis are not independent events but are coupled through a shared lipid and protein economy. A fibroblast in culture, for example, internalizes an area of membrane equivalent to its entire surface every 1–2 hours through constitutive pinocytosis. Without compensatory exocytosis from the secretory pathway and recycling endosomes, the cell would shrink dramatically. Conversely, rapidly secreting cells such as neurons at active synapses must retrieve fused vesicle membrane through rapid endocytosis (often clathrin-mediated) to sustain high-frequency neurotransmitter release without uncontrolled expansion of the presynaptic terminal.

SECTION 6

Worked Example — Tracing the LDL Receptor Pathway

The LDL (low-density lipoprotein) receptor pathway is the textbook example of receptor-mediated endocytosis. This worked example traces a single LDL particle from the bloodstream to cholesterol release inside a hepatocyte, identifying each molecular player and compartment.

LDL Particle Internalization and Processing

  1. 1

    Step 1 — Ligand Binding at the Cell Surface

    A circulating LDL particle (diameter ~22 nm, carrying ~1,500 cholesterol esters) encounters a hepatocyte expressing LDL receptors (LDLRs) on its surface. The apolipoprotein B-100 (ApoB-100) on the LDL surface binds the ligand-binding domain of the LDLR with Kd ≈ 10⁻⁹ M (nanomolar affinity). Each hepatocyte expresses approximately 20,000–50,000 LDLRs.
    LDL particle bound to LDLR at the plasma membrane.
  2. 2

    Step 2 — Clathrin-Coated Pit Assembly

    The LDL–LDLR complex migrates laterally into a clathrin-coated pit. AP2 recognizes the NPXY motif (Asn-Pro-X-Tyr) in the LDLR cytoplasmic tail and recruits clathrin triskelia, which polymerize into a polyhedral lattice. The pit invaginates, concentrating ~800 LDL–LDLR complexes in a single pit (diameter ~150 nm).
    ~800 LDL–LDLR complexes concentrated in a clathrin-coated pit.
  3. 3

    Step 3 — Scission and Uncoating

    Dynamin polymerizes around the pit neck and, upon GTP hydrolysis, constricts and severs the membrane, releasing a clathrin-coated vesicle into the cytoplasm. Auxilin recruits Hsc70, whose ATPase activity disassembles the clathrin coat within seconds, freeing the triskelia for reuse.
    Uncoated endocytic vesicle containing LDL–LDLR complexes.
  4. 4

    Step 4 — Endosomal Sorting

    The vesicle fuses with the early endosome (pH ≈ 6.0). The mild acidity induces a conformational change in the LDLR that releases the LDL particle. The free LDLR is sorted into tubular extensions of the early endosome and recycled back to the plasma membrane via recycling endosomes, ready to bind another LDL particle. The entire receptor recycling trip takes approximately 10 minutes.
    LDLR recycled to surface; free LDL particle remains in the endosomal lumen.
  5. 5

    Step 5 — Lysosomal Degradation and Cholesterol Release

    The early endosome matures into a late endosome/multivesicular body (pH ≈ 5.0), which then fuses with lysosomes (pH ≈ 4.5–5.0). Lysosomal acid lipase hydrolyzes the cholesterol esters, releasing free cholesterol. This cholesterol suppresses transcription of the LDLR gene and HMG-CoA reductase (the rate-limiting enzyme in endogenous cholesterol synthesis) via the SREBP pathway, completing a negative-feedback loop.
    Free cholesterol released; LDLR gene expression downregulated; cellular cholesterol homeostasis maintained.
⚠

Clinical Connection

Mutations in the LDLR gene cause familial hypercholesterolemia (FH). Heterozygous FH (1 in 250 individuals) roughly doubles serum LDL-cholesterol, while homozygous FH (1 in 250,000) elevates it 4–6-fold. These patients develop premature atherosclerosis because their cells cannot efficiently clear LDL from the bloodstream. Goldstein and Brown's elucidation of this pathway earned them the 1985 Nobel Prize and directly inspired the development of statin drugs, which upregulate LDLR expression by inhibiting HMG-CoA reductase.

SECTION 7

Strengths, Limitations & Comparisons

Vesicular transport pathways offer distinct advantages and constraints compared to other membrane transport mechanisms. Understanding where endocytosis and exocytosis sit within the broader landscape of cellular transport—from simple diffusion to channel-mediated ion flux—clarifies why cells invest substantial energy in vesicle-based strategies for certain cargo types.

Transport ModeStrengthsLimitations
PhagocytosisCan internalize entire bacteria and cellular debris; essential for innate immunity; highly regulated by opsonin signalsLimited to professional phagocytes; slow (minutes); energy-intensive (actin polymerization + lysosomal processing)
PinocytosisConstitutive; occurs in virtually all eukaryotic cells; samples the extracellular environment continuouslyNon-selective; cannot concentrate specific solutes; limited volume per vesicle
Receptor-Mediated EndocytosisHighly selective and efficient; can concentrate ligands > 1,000-fold; receptors recycledRequires specific receptors; exploited by pathogens (e.g., viruses hijack CME); receptor saturation at high ligand concentrations
Constitutive ExocytosisContinuous secretion; maintains membrane supply; delivers proteins to cell surfaceLacks temporal control; not suited for rapid signaling events
Regulated ExocytosisRapid, stimulus-dependent release; enables synaptic transmission and hormonal signalingRequires specialized Ca²⁺ sensors; vesicle pool can be depleted during sustained activity (synaptic fatigue)

Comparison of vesicular transport modes: strengths and limitations

✦

KEY TAKEAWAY

Consider vesicular transport as analogous to a logistics system using shipping containers (vesicles) rather than individual package mail (channels/carriers). Phagocytosis is like a flatbed truck hauling an oversized load. Pinocytosis is a regular delivery van picking up whatever happens to be at the depot. Receptor-mediated endocytosis is a premium courier service with signed receipts—only the correct package (ligand) with the right address label (receptor specificity) is accepted. Exocytosis is the outbound shipping lane from the same dock, where finished goods depart on schedule or on-demand.

SECTION 8

Connections to Advanced Theory

The principles of endocytosis and exocytosis extend far beyond simple nutrient uptake and secretion. They intersect with signal transduction, membrane trafficking networks, and disease pathogenesis in ways that continue to shape modern biomedical research. Understanding the basic vesicle machinery provides a launchpad into several advanced topics.

Core Concept (This Lesson)Advanced Extension
Clathrin-coated vesiclesClathrin-independent endocytosis (CLIC/GEEC, FEME); caveolae-mediated uptake; macropinocytosis in cancer cells for nutrient scavenging
Dynamin GTPase scissionBAR-domain proteins sensing and inducing membrane curvature; ESCRT machinery in multivesicular body formation and viral budding
SNARE-mediated exocytosisMunc18/Munc13 regulatory proteins; synaptic vesicle cycle and short-term plasticity; botulinum toxin cleavage of SNAREs
Receptor recycling via endosomesRetromer complex and Wnt signaling; endosomal signaling (signaling endosomes); receptor ubiquitination and ESCRT-mediated sorting
LDL receptor pathwayPCSK9-mediated LDLR degradation; therapeutic PCSK9 inhibitors (evolocumab, alirocumab); receptor-mediated transcytosis across endothelial barriers

From foundational vesicular transport to advanced research frontiers

A particularly active area of research involves the role of endocytosis in regulating receptor tyrosine kinase (RTK) signaling. The classical view held that endocytosis simply attenuated signaling by removing activated receptors from the surface. However, it is now appreciated that RTKs such as the EGF receptor continue to signal from endosomal compartments, and the spatial context of signaling (surface versus endosome) can alter downstream pathway selection. In cancer biology, mutations that impair endocytic downregulation of RTKs—such as EGFRvIII in glioblastoma—can lead to constitutive proliferative signaling. Similarly, many viruses exploit receptor-mediated endocytosis for cell entry: SARS-CoV-2, for instance, can enter cells via clathrin-mediated endocytosis following ACE2 receptor binding, with endosomal acidification activating the fusion machinery of the viral spike protein.

💡

Looking Ahead

Modern techniques such as cryo-electron tomography and single-molecule fluorescence imaging are revealing the dynamics of coat assembly, SNARE zippering, and membrane fusion at unprecedented resolution. Courses in advanced cell biology, biophysics of membranes, and molecular pharmacology build directly on the endocytosis/exocytosis framework presented here.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A neutrophil encounters a bacterium that has been coated with IgG antibodies (opsonized). Which type of endocytosis will the neutrophil employ, and why is actin polymerization rather than clathrin coating the primary driving force?
Show answer
The neutrophil will use phagocytosis. The opsonized bacterium is recognized by Fc receptors on the neutrophil surface, triggering signaling cascades (involving Rho-family GTPases such as Rac1 and Cdc42) that activate the Arp2/3 complex. Branched actin networks push the membrane outward as pseudopods that engulf the bacterium. Clathrin-coated pits typically form vesicles of ~100–150 nm, far too small to accommodate a bacterium that may be 1–5 µm in length. Actin-driven pseudopod extension can mold the membrane around particles of virtually any size, making it the mechanically appropriate strategy for phagocytosis.

Question 2: BASIC CALCULATION

A cultured fibroblast has a surface area of approximately 2,000 µm². If constitutive pinocytosis removes membrane at a rate equivalent to the entire surface area every 90 minutes, and each pinocytic vesicle has a diameter of 100 nm, estimate the number of vesicles formed per minute. (Assume spherical vesicles.)
Show answer
Surface area of one vesicle: A = 4πr² = 4π(50 × 10⁻³ µm)² ≈ 4π(2.5 × 10⁻³ µm²) ≈ 3.14 × 10⁻² µm². Total membrane internalized per minute: 2,000 µm² ÷ 90 min ≈ 22.2 µm²/min. Number of vesicles per minute: 22.2 µm²/min ÷ 3.14 × 10⁻² µm²/vesicle ≈ 707 vesicles per minute. This estimate illustrates the extraordinary rate of membrane turnover in a typical cell and underscores why recycling pathways are essential to maintain plasma membrane integrity.

Question 3: INTERMEDIATE

Explain why treating a cell with a dominant-negative dynamin mutant (dynamin K44A, which cannot hydrolyze GTP) would inhibit receptor-mediated endocytosis but would be expected to have little effect on constitutive exocytosis. In your answer, identify the specific step that dynamin catalyzes.
Show answer
Dynamin is a large GTPase that polymerizes around the neck of budding endocytic vesicles and, upon GTP hydrolysis, constricts to sever the vesicle from the plasma membrane. The K44A mutant binds GTP but cannot hydrolyze it, trapping the dynamin ring in a locked conformation around the vesicle neck. This prevents scission, so deeply invaginated clathrin-coated pits accumulate at the cell surface but cannot be released as free vesicles—receptor-mediated endocytosis is blocked. Exocytosis, by contrast, involves vesicle fusion with the plasma membrane catalyzed by SNARE proteins (not dynamin). SNARE-mediated membrane fusion and pore opening are dynamin-independent processes, so constitutive exocytosis proceeds normally even when dynamin function is abolished.

Question 4: APPLIED

A patient is diagnosed with homozygous familial hypercholesterolemia caused by a Class 2 mutation in the LDL receptor gene (the receptor is synthesized but cannot fold properly in the ER and is degraded by ERAD). Explain why this patient has dramatically elevated serum LDL-cholesterol, and predict whether administering a statin drug alone would be sufficient to normalize their cholesterol levels.
Show answer
In a Class 2 LDLR mutation, the receptor protein is translated but misfolds in the endoplasmic reticulum, triggering ER-associated degradation (ERAD). As a result, virtually no functional LDLRs reach the cell surface. Hepatocytes—which normally clear ~70% of circulating LDL via receptor-mediated endocytosis—cannot internalize LDL particles, causing severe hypercholesterolemia (often > 500 mg/dL). Statins work by inhibiting HMG-CoA reductase, reducing intracellular cholesterol, and activating SREBP-mediated transcription of the LDLR gene. However, if the receptor protein cannot fold and traffic to the surface regardless of transcriptional upregulation, increasing LDLR mRNA provides minimal benefit. Therefore, statins alone are insufficient for homozygous Class 2 FH. These patients typically require LDL apheresis, PCSK9 inhibitors (which only help if some functional receptor reaches the surface), or liver transplantation.

Question 5: CRITICAL THINKING

Some enveloped viruses (e.g., influenza) exploit receptor-mediated endocytosis for cell entry and depend on endosomal acidification to trigger viral-membrane fusion. Other enveloped viruses (e.g., HIV) fuse directly with the plasma membrane at neutral pH. Design an experimental strategy using pharmacological inhibitors to determine which entry pathway a newly discovered enveloped virus uses. Specify at least two drugs, their targets, and the predicted outcomes for each entry mechanism.
Show answer
Two informative inhibitors are: (1) Chlorpromazine, which inhibits clathrin-coated pit formation by redistributing clathrin and AP2 to intracellular compartments, and (2) Bafilomycin A1, a V-ATPase inhibitor that blocks endosomal acidification. If the virus enters via receptor-mediated endocytosis and requires low pH for fusion (like influenza), both chlorpromazine and bafilomycin A1 should independently inhibit infection: chlorpromazine by preventing internalization of the virus–receptor complex, and bafilomycin A1 by preventing the pH drop that triggers the conformational change in the viral fusion protein. If the virus fuses at the plasma membrane at neutral pH (like HIV), neither drug should significantly reduce infection—chlorpromazine will not block surface fusion, and endosomal pH is irrelevant to entry. A third control could be dynasore (a dynamin GTPase inhibitor), which would block scission of endocytic vesicles and thereby inhibit the endosomal-entry pathway but not plasma membrane fusion. Quantification of viral gene expression or progeny virus production under each condition would conclusively distinguish the two mechanisms.

SUMMARY

Lesson Summary

Summary

Cells move macromolecules and particles across the plasma membrane through vesicular (bulk) transport. Endocytosis internalizes material via membrane invagination and vesicle budding. Its three major subtypes are phagocytosis (actin-driven engulfment of large particles), pinocytosis (non-selective uptake of fluid in small vesicles), and receptor-mediated endocytosis (clathrin-coated pit internalization of specific ligands bound to surface receptors). Key molecular players include clathrin triskelia and AP2 adaptors for coat assembly, and dynamin for vesicle scission.

Exocytosis is the complementary process: intracellular vesicles fuse with the plasma membrane via SNARE protein complexes (v-SNAREs on vesicles, t-SNAREs on target membranes), releasing cargo extracellularly and adding membrane to the cell surface. Constitutive exocytosis maintains the secretory pathway continuously, while regulated exocytosis requires a Ca²⁺ signal for rapid, stimulus-dependent release (e.g., neurotransmission, insulin secretion). The balance between endocytosis and exocytosis maintains membrane homeostasis, and disruptions in either pathway underlie diseases ranging from familial hypercholesterolemia to neurological disorders and susceptibility to viral infections.

Varsity Tutors • Cell Biology • Endocytosis & Exocytosis